These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
893 related items for PubMed ID: 31438892
1. Reduction of metastatic potential by inhibiting EGFR/Akt/p38/ERK signaling pathway and epithelial-mesenchymal transition after carbon ion exposure is potentiated by PARP-1 inhibition in non-small-cell lung cancer. Chowdhury P, Dey P, Ghosh S, Sarma A, Ghosh U. BMC Cancer; 2019 Aug 22; 19(1):829. PubMed ID: 31438892 [Abstract] [Full Text] [Related]
2. Gamma ray-induced in vitro cell migration via EGFR/ERK/Akt/p38 activation is prevented by olaparib pretreatment. Chowdhury P, Dey P, De D, Ghosh U. Int J Radiat Biol; 2020 May 22; 96(5):651-660. PubMed ID: 31914341 [Abstract] [Full Text] [Related]
3. Inactivation of M2 AChR/NF-κB signaling axis reverses epithelial-mesenchymal transition (EMT) and suppresses migration and invasion in non-small cell lung cancer (NSCLC). Zhao Q, Yue J, Zhang C, Gu X, Chen H, Xu L. Oncotarget; 2015 Oct 06; 6(30):29335-46. PubMed ID: 26336823 [Abstract] [Full Text] [Related]
4. RIP1 Is a Novel Component of γ-ionizing Radiation-Induced Invasion of Non-Small Cell Lung Cancer Cells. Kang AR, Cho JH, Lee NG, Song JY, Hwang SG, Lee DH, Um HD, Park JK. Int J Mol Sci; 2020 Jun 28; 21(13):. PubMed ID: 32605153 [Abstract] [Full Text] [Related]
5. The crosstalk between p38 and Akt signaling pathways orchestrates EMT by regulating SATB2 expression in NSCLC cells. Kucuksayan H, Akca H. Tumour Biol; 2017 Sep 28; 39(9):1010428317706212. PubMed ID: 28937318 [Abstract] [Full Text] [Related]
6. Hydroxysafflor yellow A inhibited lipopolysaccharide-induced non-small cell lung cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT/mTOR and ERK/MAPK signaling pathways. Jiang M, Zhou LY, Xu N, An Q. Thorac Cancer; 2019 Jun 28; 10(6):1319-1333. PubMed ID: 31055884 [Abstract] [Full Text] [Related]
7. PARP-1 induces EMT in non-small cell lung carcinoma cells via modulating the transcription factors Smad4, p65 and ZEB1. Kumar M, Jaiswal RK, Prasad R, Yadav SS, Kumar A, Yadava PK, Singh RP. Life Sci; 2021 Mar 15; 269():118994. PubMed ID: 33417952 [Abstract] [Full Text] [Related]
8. PDGF-D/PDGFRβ promotes tongue squamous carcinoma cell (TSCC) progression via activating p38/AKT/ERK/EMT signal pathway. Zhang H, Sun JD, Yan LJ, Zhao XP. Biochem Biophys Res Commun; 2016 Sep 16; 478(2):845-51. PubMed ID: 27507215 [Abstract] [Full Text] [Related]
9. Inhibition of CXCR4 regulates epithelial mesenchymal transition of NSCLC via the Hippo-YAP signaling pathway. Zheng CH, Chen XM, Zhang FB, Zhao C, Tu SS. Cell Biol Int; 2018 Sep 16; 42(10):1386-1394. PubMed ID: 29972256 [Abstract] [Full Text] [Related]
10. Isorhamnetin inhibited migration and invasion via suppression of Akt/ERK-mediated epithelial-to-mesenchymal transition (EMT) in A549 human non-small-cell lung cancer cells. Luo W, Liu Q, Jiang N, Li M, Shi L. Biosci Rep; 2019 Sep 30; 39(9):. PubMed ID: 31467176 [Abstract] [Full Text] [Related]
11. Γ-Ionizing radiation-induced activation of the EGFR-p38/ERK-STAT3/CREB-1-EMT pathway promotes the migration/invasion of non-small cell lung cancer cells and is inhibited by podophyllotoxin acetate. Cho JH, Hong WG, Jung YJ, Lee J, Lee E, Hwang SG, Um HD, Park JK. Tumour Biol; 2016 Jun 30; 37(6):7315-25. PubMed ID: 26671552 [Abstract] [Full Text] [Related]
12. SSPH I, A Novel Anti-cancer Saponin, Inhibits EMT and Invasion and Migration of NSCLC by Suppressing MAPK/ERK1/2 and PI3K/AKT/ mTOR Signaling Pathways. Zhou J, Luo J, Gan R, Zhi L, Zhou H, Lv M, Huang Y, Liang G. Recent Pat Anticancer Drug Discov; 2024 Jun 30; 19(4):543-555. PubMed ID: 38305308 [Abstract] [Full Text] [Related]
13. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis. Lu C, Shan Z, Hong J, Yang L. Int J Oncol; 2017 Jul 30; 51(1):235-244. PubMed ID: 28534966 [Abstract] [Full Text] [Related]
14. Kinase switching in mesenchymal-like non-small cell lung cancer lines contributes to EGFR inhibitor resistance through pathway redundancy. Thomson S, Petti F, Sujka-Kwok I, Epstein D, Haley JD. Clin Exp Metastasis; 2008 Jul 30; 25(8):843-54. PubMed ID: 18696232 [Abstract] [Full Text] [Related]
15. MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer. Ma K, Fan Y, Dong X, Dong D, Guo Y, Wei X, Ning J, Geng Q, Wang C, Hu Y, Li M, Niu W, Li E, Wu Y. Oncotarget; 2017 Jun 13; 8(24):38825-38840. PubMed ID: 28418915 [Abstract] [Full Text] [Related]
16. The role of Axl in drug resistance and epithelial-to-mesenchymal transition of non-small cell lung carcinoma. Wu F, Li J, Jang C, Wang J, Xiong J. Int J Clin Exp Pathol; 2014 Jun 13; 7(10):6653-61. PubMed ID: 25400744 [Abstract] [Full Text] [Related]
18. CD146 Promotes EMT-Mediated Migration and Invasion of NSCLC via PI3K/Akt Signaling Pathway. Wei N, Wu X, Yu Y, Zhou H, Cui K, Zhao X, Zhang X. Front Biosci (Landmark Ed); 2024 Apr 08; 29(4):140. PubMed ID: 38682195 [Abstract] [Full Text] [Related]
19. IDH-Inhibiting Small Molecule DTDQ Inhibits Migration and Invasion of A549 Human Non-Small-Cell Lung Cancer Cells via Sequential Inactivation Of ERK and P38 Signaling Pathways. Park S, Lee J, Lee SY. Cell Biochem Biophys; 2018 Jun 08; 76(1-2):255-263. PubMed ID: 28321613 [Abstract] [Full Text] [Related]
20. Ginkgolic Acid Inhibits Invasion and Migration and TGF-β-Induced EMT of Lung Cancer Cells Through PI3K/Akt/mTOR Inactivation. Baek SH, Ko JH, Lee JH, Kim C, Lee H, Nam D, Lee J, Lee SG, Yang WM, Um JY, Sethi G, Ahn KS. J Cell Physiol; 2017 Feb 08; 232(2):346-354. PubMed ID: 27177359 [Abstract] [Full Text] [Related] Page: [Next] [New Search]